CSBR icon

Champions Oncology
CSBR

Overview Fund Activity

30 hedge funds and large institutions have $23.6M invested in Champions Oncology in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
8
Reduced
6
Closed
1
Calls
$33K
Puts
$66K
Net Calls
-$33K
Net Calls Change
-$28K

Top Buyers

1
TAM
1
Tocqueville Asset Management
New York
$2.68M
2
Bank of America
2
Bank of America
North Carolina
$104K
3
Stifel Financial
3
Stifel Financial
Missouri
$89.7K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$7K
5
Morgan Stanley
5
Morgan Stanley
New York
$36.6K

Top Sellers

1
MAG
1
Millrace Asset Group
Pennsylvania
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$50.2K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$508K
4
BlackRock
4
BlackRock
New York
$466K
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$467K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$10K +$2.63K +698 +36%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$7K +$6.38K +1,518 +1,026%
SFG
28
Steward Financial Group
Texas
$3K – – –
Wells Fargo
29
Wells Fargo
California
$173 +$4 +1 +2%
MAG
30
Millrace Asset Group
Pennsylvania
– -$875K -194,010 Closed
1
2